Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2200 of 3284 entries
View as:

Pharmacokinetics of Extended-Release Test- and Reference Formulations of AZD0837

Phase: N/A Priority: Normal
NCT ID: NCT00878618 Org: User:
Start: 04/30/09 End: 05/31/09 Due: 05/31/10

Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)

Phase: N/A Priority: Normal
NCT ID: NCT00546520 Org: User:
Start: 04/30/02 End: 06/30/02 Due: 06/30/03

Depressive Symptoms in Acute Manic Episode

Phase: N/A Priority: Normal
NCT ID: NCT00690248 Org: User:
Start: 11/30/07 End: 12/31/08 Due: 12/31/09

AZD6738 First Time in Patient Multiple Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT01955668 Org: User:
Start: 11/30/13 End: 12/31/13 Due: 12/31/14

Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children

Phase: N/A Priority: Normal
NCT ID: NCT00641472 Org: User:
Start: 10/31/02 End: 02/28/05 Due: 02/28/06

Seroquel on Glucose Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT00214578 Org: User:
Start: 04/30/04 End: 10/31/05 Due: 10/31/06

Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02197234 Org: User:
Start: 12/22/14 End: 06/03/24 Due: 06/03/25

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05084755 Org: User:
Start: 11/11/21 End: 09/16/22 Due: 09/16/23

Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01047553 Org: User:
Start: 12/31/09 End: 07/31/11 Due: 07/31/12

Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00241423 Org: User:
Start: 10/31/05 End: 06/30/07 Due: 06/30/08

Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT03101839 Org: User:
Start: 05/15/17 End: 01/08/19 Due: 01/08/20

Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia

Phase: N/A Priority: Normal
NCT ID: NCT01027624 Org: User:
Start: 11/30/09 End: 04/30/10 Due: 04/30/11

AZD6140 Oral Contraceptive Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT00685906 Org: User:
Start: 04/30/08 End: 10/31/08 Due: 10/31/09

AZD8529 Multiple Ascending Dose Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00765492 Org: User:
Start: 10/31/08 End: 03/31/09 Due: 03/31/10

A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT03649165 Org: User:
Start: 09/05/18 End: 10/21/18 Due: 10/21/19

A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01235741 Org: User:
Start: 01/31/11 End: 09/30/11 Due: 09/30/12

A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium

Phase: N/A Priority: Normal
NCT ID: NCT00949975 Org: User:
Start: 07/31/09 End: 08/31/10 Due: 08/31/11

AZD9291 First Time In Patients Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT01802632 Org: User:
Start: 03/04/13 End: 12/13/23 Due: 12/13/24

A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04995523 Org: User:
Start: 09/14/21 End: 03/16/28 Due: 03/16/29

Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00885378 Org: User:
Start: 05/31/09 End: 02/28/10 Due: 02/28/11

AZD9668 Relative Bioavailability

Phase: N/A Priority: Normal
NCT ID: NCT01035411 Org: User:
Start: 11/30/09 End: 12/31/09 Due: 12/31/10

A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01233232 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic Treatments

Phase: N/A Priority: Normal
NCT ID: NCT01086280 Org: User:
Start: 01/31/10 End: 12/31/15 Due: 12/31/16

Comparison Between Symbicort® and Prednisolone in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00259779 Org: User:
Start: 09/30/05 End: 07/31/07 Due: 07/31/08

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00703534 Org: User:
Start: 05/31/08 End: 01/31/09 Due: 01/31/10